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Introduction
In the United Kingdom, the National Institute for 
Health and Clinical Excellence provides guidance 
that recommends combining physical and psycholog-
ical therapies and providing individually tailored self-
management support for people experiencing 
long-term musculoskeletal pain.1,2 Although there is 
promising evidence that psychological methods and 
self-management programmes (SMPs) improve self-
reported outcomes for adults with various pain condi-
tions, and specifically for chronic musculoskeletal 
pain3–8 in research studies, there is limited evidence 
on which to base decisions about the type and content 
of SMPs for health services commissioners.9 This ser-
vice evaluation study examines the uptake and effect 
on patient-reported outcomes of an evidence-based 
group SMP within usual health services provision of 
in two health economies in England.
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Abstract
In the United Kingdom, chronic pain affects approximately 28 million adults, creating significant 
healthcare and socio-economic costs. The aim was to establish whether a programme designed to use 
best evidence of content and delivery will be used by patients with significant musculoskeletal pain 
problems. Of 528 patients recruited, 376 participated in a 7-week-long group-based self-management 
programme (SMP) co-delivered by clinical and lay tutors. Of these, 308 patients (mean age, 53 years; 69% 
females, 94% White) completed at least five SMP sessions. Six months after pre-course assessment, 
participants reported significantly improved patient activation and health status, lower depression and 
anxiety scores, decreased pain severity and interference, and improved self-management skills. There 
were no improvements in health state and pain self-efficacy. Uptake rate was 71% and completion 82%. 
The results should be of value to commissioners of pathways of care for the large numbers of patients 
attending the English NHS for chronic musculoskeletal pain.
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Background
It is estimated that in the United Kingdom, chronic 
pain affects just under 28 million people.10 
Musculoskeletal pain accounts for around 15% of all 
general practitioner (GP) consultations.11 It is esti-
mated that the total healthcare costs for patients with 
chronic lower back pain were double those of the 
matched controls in the United Kingdom (£1074 ver-
sus £516; p < 0.05).12 Of this cost difference, almost 
60% was accounted for by General Practice consulta-
tions, and 22% by secondary care referrals and the rest 
by pain relief medications.12
Although research to date provides only limited evi-
dence to inform the design of primary care and com-
munity services that could be commissioned in the 
United Kingdom, some studies suggest that SMPs can 
improve outcomes in people living with chronic condi-
tions including musculoskeletal pain.13–16 The US 
Institute of Medicine defines self-management as ‘the 
tasks that individuals must undertake to live with one 
or more chronic conditions. These tasks include having 
the confidence to deal with medical management, role 
management and emotional management of their con-
ditions’.17 Lorig and Holman18 describe six main self-
management skills: problem solving, decision making, 
resource utilisation, formation of a patient-provider 
partnership, action planning and self-tailoring. Self-
efficacy, described as the confidence that one can carry 
out behaviours necessary to reach one’s goals, is an 
important concept underpinning SMPs.19
A recent systematic review of SMPs for patients 
with musculoskeletal pain concluded that SMPs for 
patients with arthritis have small to moderate long-
term effects in improving pain and disability, but there 
is not enough evidence to draw conclusions about the 
effectiveness of interventions designed for patients 
with chronic back pain.13 A systematic review of effec-
tive delivery styles and content of self-management 
interventions for chronic musculoskeletal pain14 pro-
vided evidence for the clinical effectiveness of group 
delivered interventions lead by a healthcare profes-
sional having more beneficial effects than lay-led pro-
grammes (although paying clinicians adds costs). 
There was mixed evidence for the effectiveness of dif-
ferent intervention components; however programmes 
with a psychological component produced better out-
comes than those without these components.14
A randomised controlled trial (RCT) of the effec-
tiveness and cost-utility of a group self-management 
support intervention for people with chronic musculo-
skeletal pain showed that in the intervention group at 
6 months after completing the programme, self-effi-
cacy, pain acceptance and social integration improved, 
and the level of anxiety and depression decreased sig-
nificantly compared to two control conditions of usual 
care and using an audio relaxation aid. At 12 months 
after completing the programme, positive changes 
achieved by patients from the intervention group 
remained significant for depression and social integra-
tion. However, the programme had no effect on pain-
related disability at any follow-up point.15
Another RCT compared the effectiveness of an out-
patient Pain Self-management Programme (PSM) for 
patients over 65 using cognitive-behavioural therapy 
(CBT) and exercise with two control conditions.16 
Patients who completed the PSM, compared to other 
two groups, significantly improved on measures of pain 
distress, disability, mood, unhelpful pain beliefs and 
functional reach, and these changes were sustained 
1 month after completing the programme.
Aim
The aim of this study was to establish the uptake, 
retention and outcomes of an evidence-based self-
management intervention in the context of National 
Health Service provision which is open to patients who 
self-refer themselves to the programme after discussion 
with their GP or hospital specialist clinician, rather 
than in the conditions of a clinical trial. We aimed to 
establish if the programme improves patients’ self-
reported activation and confidence to self-manage, 
their use of self-management skills, their mood and 
health-related quality of life. Second, we sought to 
determine the patient characteristics of those who 
attended and those who most benefited from the pro-
gramme to inform future health service provision.
Materials and methods
Recruitment
The study protocol was approved by the NHS Research 
Ethics Committee 07/H1107/143. Patients eligible for 
inclusion were aged 18 years or older, diagnosed with 
chronic musculoskeletal pain, and who were physically 
able to attend a group-based SMP. Patients seen in pri-
mary or secondary care settings were recruited for the 
study between February 2008 and June 2010. Eligible 
patients were informed by their providers about the 
programme and received instructions on how to enrol. 
Patients registered their interest via a dedicated recruit-
ment telephone helpline.
Intervention
The SMP for people living with chronic musculoskel-
etal pain was delivered as a part of the Co-Creating 
Health (CCH) programme. CCH is a quality improve-
ment programme commissioned by the Health 
Foundation which aimed to demonstrate that increased 
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self-management support leads to improved health 
and self-management outcomes. The programme was 
delivered at two National Health Service organisations: 
Calderdale and Kirklees Primary Care NHS Trusts 
with Calderdale and Huddersfield NHS Foundation 
Trust, and North Bristol NHS trust with Bristol 
Primary Care NHS Trust.
The SMP was a 21-hour (7-week long, 3-hour per 
session) group-based SMP co-delivered by a ‘clinical 
tutor’ (e.g. physiotherapist, clinical psychologist or 
anaesthetist) and a ‘peer tutor’ (a person living with the 
condition). Some of the structure, content and theory 
of the CCH SMP were based on the Stanford University 
Chronic Disease Self-Management Course,18 which in 
the United Kingdom is known as the Expert Patients’ 
Programme (EPP). The SMP contains 27 behaviour 
change techniques, including those that have a strong 
evidence base such as goal setting, action planning and 
problem solving,19 plus weekly pain-specific content. 
The intervention delivery of the SMP was guided by a 
manual to ensure consistency of delivery and content, 
supporting intervention fidelity.20,21
Tutors were trained and accredited to a rigorous set 
of quality standards with training and course delivery 
focusing on adherence to the activity times and 
sequence of activities as set out in the manual.
Measures
Data were collected before attending the SMP (T1) 
and 6 months after completing the programme (T2).
Patient Activation Measure. The Patient Activation 
Measure (PAM) assesses patient activation,22 which is 
conceptually similar to self-efficacy. It comprises 13 
items assessing patient knowledge, skill and confidence 
for self-management. Scores range from 0 to 100; 
higher scores indicate greater activation. An improve-
ment in 4 points on the PAM scale is considered a 
minimal clinically important difference (MCID).23–25 
The PAM is the primary outcome measure and has 
since been mandated for use in the NHS in England 
(https://www.england.nhs.uk/ourwork/patient-partici-
pation/self-care/patient-activation/pa-faqs/).
Hospital Anxiety and Depression Scale. The Hospital 
Anxiety and Depression Scale (HADS)26 provides sep-
arate scores for anxiety and depression ranging from 0 
to 21, with higher scores indicating greater anxiety and 
greater depression. Based on effect size approach, the 
MCID is 1.40 for the HADS depression score and 
1.32 for the HADS anxiety score.27
EuroQol. EuroQol is a measure of health-related qual-
ity of life.28 It consists of a descriptive measure of 
health status (EQ 5D index)29 assessing patients’ health 
state across five dimensions (self-care, mobility, anxi-
ety/depression, usual activities and pain/discomfort), 
and a visual analogue measure (EQ VAS)30 valuing 
respondent’s health state with endpoints of best and 
worst imaginable health state. Improvement by at least 
30 points is MCID for EQ VAS,31,32 while for EQ 5D it 
is a mean change of 0.037 and standard deviation (SD) 
0.008.33
Health Education Impact Questionnaire. Health Educa-
tion Impact Questionnaire (heiQ) is a measure of self-
management ability.34 The eight scales are positive and 
active engagement in life, health directed behaviour, 
skill and acquisition technique, constructive attitudes 
and approaches, self-monitoring and insight, health 
services navigation, social integration and support, and 
emotional well-being. Items are rated on a 4-point Lik-
ert scale; higher scores represent higher levels of self-
management abilities.
Brief Pain Inventory and Pain Self-Efficacy Question-
naire. The Brief Pain Inventory (BPI) includes two sub-
scales: Pain Severity that assesses the pain at its worst, 
average, least and now, and Pain Interference assessing 
how much pain affects the person’s daily activities.35 A 
2-point reduction in pain from a baseline of 4 was con-
sidered clinically meaningful by patients; therefore, a 
low-end cut-off point level of either 4 or 5 on the 
11-point numeric rating scale is considered MCID in 
patient-based studies.36 The Pain Self-Efficacy Ques-
tionnaire (PSEQ) is a 10-item questionnaire assessing 
how confident patients are in performing a range of 
activities including household chores, socialising with 
friends and family, work and hobbies.37 The score 
change of 8.5 on the PSEQ is considered to be MCID.38
Data analysis
All data analyses were conducted using IBM SPSS 
Statistics 20. The main analysis was a per-protocol 
analysis, which included only patients who attended ≥5 
SMP sessions (defined as course completers) and who 
returned 6-month follow-up questionnaires. The level 
of statistical significance was set at p = 0.05.
Intention-to-treat (ITT) analysis was performed to 
ensure that the effectiveness of the programme has not 
been overestimated.39,40 To replace missing data, we used 
a single imputation method41 replacing missing T2 data 
with T1 data. Changes in the mean values of the patient 
outcomes were compared over time using paired T Tests. 
Liner regression was applied to test whether prognostic 
factors (T1 scores) and demographic variables predicted 
changes in primary and secondary outcomes at 6 months. 
Effect sizes (Cohen’s d) were calculated with boundaries 
of small (0.2), moderate (0.5) and large (0.8) effect 
sizes.42 Three categories of change of heiQ scores were 
Anderson and Wallace 107
defined: ‘substantial improvement’ (Effective Size 
(ES) ≥ 0.5), ‘minimal/no change’ (–0.50 < ES < 0.50) and 
‘substantial decline’ (ES ≤ –0.5).34
Results
Demographic variables
In total, 528 pain patients registered with the recruit-
ment helpline. Of these 152 patients did not attend the 
SMP, 376 attended at least one session and 308 com-
pleted at least five sessions. Some 336 patients com-
pleted baseline questionnaires, and 149 patients (44%) 
completed the primary outcome measure (PAM) at 
6-month follow-up.
Patient characteristics are summarised in Table 1. 
Patients were on average 53 years of age, predomi-
nantly White (94%) and female (69.4%). Overall, 
74.7% owned their own home and 20% lived alone. 
Just over a quarter (26%) was in full- or part-time 
employment. Over a half (51.2%) left education 
between 16 and 19 years of age, and 21% were edu-
cated post 19 years of age.
SMP completers were predominantly White, while 
there was a higher ratio of patients of other ethnic ori-
gin among those who dropped out of the SMP 
(χ2 = 5.62 (1); p < 0.05). Non-completers also scored 
significantly lower at baseline (Time 1) on Self-
Monitoring and Insight subscale of heiQ (M = 2.82, 
SD = 0.52) compared to those who completed the 
SMP (M = 2.97, SD = 0.45; t = –2.93 (361), p = 0.004, 
d = 0.28). There were no other differences between 
completers and non-completers.
Primary outcome
Per-protocol analysis showed that patients’ activation 
significantly improved 6 months after completing the 
SMP (M = 56.6, SD = 15.6) compared to baseline level 
(M = 51.3, SD = 12.7; t = 4.75 (148), p < 0.001, 
d = –0.43; Table 2). The improvement reached the level 
of MCID.23–25 Baseline PAM score (β = .44, 
t(124) = 5.05, p < 0.001) and living situation (β = 0.24, 
t(120) = 2.8, p < 0.006) significantly predicted activa-
tion at 6 months. Baseline PAM score explained 20% 
of variance of 6 months’ PAM scores, while living situ-
ation only predicted 4%. ITT analysis produced simi-
lar results (Table 2). Some 50.3% of patients showed a 
meaningful improvement (i.e. ≥4 points) in patient 
activation scores. None of the prognostic and demo-
graphic factors predicted patient activation over time.
Secondary outcomes
Per-protocol analysis showed that patients’ health 
state (EQ-VAS) did not change 6 months after 
completing the SMP (Table 2). The difference between 
baseline and 6-month scores did not reach the level of 
MCID.31,32 However, patients’ health status (EQ 5D 
index) significantly improved 6 months after complet-
ing the SMP (M = 0.39, SD = 0.34) compared to base-
line (M = 0.30, SD = 0.33, t = –2.64 (128), p < 0.008, 
d = –0.26; Table 2). The change in score reached the 
level of MCID.33 ITT analysis produced similar 
results for both EQ-VAS and EQ 5D Index (Table 2). 
Baseline health-related quality-of-life score (β = 0.47, 
t(127) = 6.5, p < 0.0001) and employment status 
(β = –0.39, t(113) = 4.1, p < 0.0001) were significant 
predictors of health status score at 6 months, meaning 
participants who were not employed and with lower 
EQ 5D Index score at baseline showed less improve-
ment at 6 months. Baseline health status explained a 
20% of variance in follow-up score, while employment 
status explained 10%.
Per-protocol analysis showed that depression 
decreased significantly 6 months after completing the 
SMP (M = 7.61, SD = 3.78) compared to baseline 
Table 1. Characteristics of patients who enrolled on the 
SMP and returned a baseline questionnaire (N = 302).
Characteristics Mean (SD)
Age 53 (12.8)
 %
Gender
 Male 24.6
 Female 69.4
Ethnic origin
 White 94.0
 Other  6.0
Accommodation
 Owner/occupier 74.7
 Other 25.3
Living arrangements
 Live alone 19.8
 Live with spouse/partner 39.7
  Live with someone else (friend, parent, 
sibling)
40.5
Age left education
 Below 16 years 26.5
 16–18 years 51.2
 ≥19 years 20.9
Employment
 FT/PT 25.9
 Retired 36.4
 Housewife/husband 17.4
  Other (e.g. student, disability living 
allowance)
20.3
 Co-morbidity 29.3
SMP: self-management programme; SD: standard deviation; FT: 
full time; PT: part time.
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(M = 8.74, SD = 4.05, t = 2.89 (105), p = 0.005, 
d = –0.27; Table 2), reaching the level of MCID.26 Both 
baseline anxiety (β = 0.26, t(63) = 2.1, p < 0.03) and 
depression (β = –0.28, t(63) = –2.1, p < 0.03) were sig-
nificant predictors of depression level at 6 months. This 
is unsurprising as at baseline anxiety and depression 
are strongly correlated (r = 0.76; p < 0.001). Baseline 
anxiety explained 35% of variance in depression scores 
at 6 months, while baseline depression score accounted 
for 8% of variance. Of the demographic variables, only 
living situation was a weak but significant predictor of 
depression scores at 6 months (β = –0.25, t(84) = 2.3, 
p < 0.02) and accounted for 4% variance.
Anxiety decreased significantly 6 months post SMP 
(M = 9.14, SD = 4.57) compared to baseline (M = 10.33, 
SD = 4.33, t = 3.06 (105), p = 0.003, d = 0.27), reaching 
the level of MCID.26 ITT analysis produced similar 
results (Table 2). Baseline anxiety (β = 0.68, t(63) = 6.3, 
p < 0.0001) and depression (β = –0.24, t(63) = –2.1, 
p < 0.03) were significant predictors of anxiety level at 
6 months. Baseline anxiety score explained 20% of vari-
ance of anxiety score at 6-month follow-up, while base-
line depression score accounted for 10%. None of the 
demographic variables predicted anxiety level 6 months 
post intervention.
Per-protocol analysis showed that patients’ self-man-
agement skills in two out of eight heiQ domains signifi-
cantly improved 6 months after attending the SMP. 
Self-Monitoring and Insight improved significantly 
6 months after completing SMP (baseline M = 2.99, 
SD = 0.50; follow-up M = 3.11, SD = 0.48; t = 2.17 (106), 
p = 0.032, d = 0.24), as well as Skills and Technique 
Acquisition (baseline M = 2.51, SD = 0.68; follow-up 
M = 2.84, SD = 0.49; t = 4.95 (105), p < 0.001, d = 0.68). 
Effect sizes ranged from 0.50 for Skills and Technique 
Acquisition to 0.00 for Health Directed Behaviour, 
Positive and Active Engagement, Social Integration and 
support and Health Service Navigation (Table 2).
ITT analysis produced similar results for all but one 
heiQ subscales (Table 2). While per-protocol analysis 
showed no significant improvement in Social Integration 
and Support Subscale, ITT analysis provided a contra-
dictory result showing significant improvement (base-
line M = 2.58, SD = 0.71; follow-up M = 2.74, 
SD = 0.62; t = 4.10 (362), p < 0.001, d = 0.22). As shown 
in Table 3, 35% of patients showed substantial improve-
ment in Skills and Technique Acquisition and around a 
quarter in Positive and Active Engagement, Emotional 
Well-Being and Self-Monitoring and Insight. Fewer 
patients (around 20%) substantially improved in rela-
tion to Health Directed Behaviour, Constructive 
Attitude Shift, Social Integration and Support, and 
Health Service Navigation. None of the prognostic or 
demographic factors predicted heiQ subscale scores at 
6 months post intervention.
Condition specific outcomes
Per-protocol analysis showed that Pain Self-Efficacy 
level significantly decreased 6 months post SMP 
Table 2. Baseline (T1) and 6-month follow-up (T2) scores.
Outcome variable Per-protocol analysis ITT p value 
(N = 336)
N T1
Mean (SD)
T2
Mean (SD)
Effect size p value
Patient Activation Measure (0–100 = better) 149 51.4 (12.7) 56.9 (15.6) 0.43 <0.001 <0.001
EQ 5D Index (0–1 range 1 = better) 126 0.3 (0.3) 0.4 (0.3) 0.33 0.008 <0.001
EQ-VAS (0–100 range, 100 = better) 126 51.2 (18.4) 49.5 (20.8) –0.09 0.411 0.411
HADS Anxiety (0–21 range, 21 = better) 106 10.3 (4.3) 9.1 (4.6) –0.27 0.003 0.002
HADS Depression (0–21 range, 21 = better) 106 8.7 (4.0) 7.6 (3.8) –0.27 0.005 0.051
heiQ (1–4 range, 4 = better)
 Health Directed Behaviour 107 2.7 (0.6) 2.7 (0.7) 0.00 0.893 0.407
 Positive and Active Engagement 107 2.6 (0.6) 2.6 (0.7) 0.00 0.495 0.612
 Emotional Well-Being 107 2.0 (0.6) 2.1 (0.6) 0.16 0.085 0.104
 Self-Monitoring and Insight 107 3.0 (0.5) 3.1 (0.5) 0.20 0.032 0.032
 Constructive Attitude Shift 107 2.7 (0.6) 2.8 (0.6) 0.16 0.124 0.250
 Skills and Technique Acquisition 107 2.5 (0.6) 2.8 (0.5) 0.50 <0.001 <0.001
 Social Integration and Support 107 2.8 (0.7) 2.8 (0.6) 0.00 0.664 <0.001
 Health Service Navigation 107 2.9 (0.6) 2.9 (0.6) 0.00 0.880 0.884
BPI Pain Severity (0–10 range; 10 = better) 146 7.5 (1.8) 7.2 (2.1) –0.16 0.069 0.048
BPI Pain Interference (0–10 range; 10 = better) 146 6.0 (1.6) 5.9 (1.7) –0.06 0.204 <0.001
Pain Self-Efficacy (PSEQ) (0–60 range; 60 = better) 147 46.5 (13.8) 43.5 (14.9) –0.21 0.006 0.005
SD: standard deviation; ITT: intention to treat; HADS: Hospital Anxiety and Depression Scale; heiQ: Health Education Impact 
Questionnaire; BPI: Brief Pain Inventory.
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(M = 43.51, SD = 14.90) compared to pre-course level 
(M = 46.55, SD = 13.81; t = 2.78 (146), p = 0.006, 
d = –0.21), reaching the level of MCID.37 ITT analysis 
produced similar results (Table 2). Baseline Pain Self-
Efficacy level was a significant predictor of the 6-month 
follow-up score (β = 0.76, t(94) = 5.6, p < 0.0001), with 
baseline score accounting for 30% variance at follow-
up. None of the demographic variables was a predictor 
of Pain Self-Efficacy level 6 months post intervention.
Per-protocol analysis showed no improvement on 
BPI subscales (Table 2). However, ITT analysis 
showed small but significant improvement in Pain 
Severity subscale (baseline M = 7.61, SD = 1.87; fol-
low-up M = 7.44, SD = 2.03; t = 1.98 (350), p = 0.048, 
d = –0.09) and larger improvement in Pain Interference 
score (baseline M = 6.31, SD = 1.81; follow-up 
M = 6.84, SD = 2.04; t = 4.10 (360), p < 0.001, d = 0.29; 
Table 2). None of the prognostic or demographic fac-
tors predicted changes in follow-up BPI subscales.
Discussion
Results of the study showed that attending SMP for 
patients with long-term musculoskeletal conditions 
was associated with improved patient activation and 
health status, decreased depression and anxiety, and 
significant improvements in two self-management 
skills: Self-Monitoring and Insight and Skills and 
Technique Acquisition. No changes were observed in 
patient’s health state, and unexpectedly, Pain Self-
Efficacy decreased after the programme. Per-protocol 
analysis showed no changes in Pain Severity and Pain 
Interference scores; however, ITT analysis showed 
moderate but significant improvements in both areas.
The study showed the programme was feasible to be 
offered to a large number of eligible patients and had 
good levels of attendance. Those who dropped out 
were more likely to be of non-White ethnicity, suggest-
ing the course recruitment and retention could be 
improved by tailoring the recruitment strategy to 
patients of different ethnicities. Referrers and call cen-
tre staff could be trained to use motivational interview 
techniques43 to enhance patients’ positive attitudes to 
self-management techniques in general, and the use of 
self-monitoring materials given out before the course. 
Analyses by demographic and prognostic factors were 
largely not significant and do not permit us to make 
recommendations to target and support particular 
patient groups.
We compared our results to the review of 18 trials of 
chronic disease SMPs, the majority of which were for 
arthritis,44 and the Cochrane review of lay-led SMPs 
for a range of conditions.6 Attending at least five ses-
sions of the SMP programme resulted in significant 
improvements in patient activation with half gaining a 
4-point or more improvement. In studies reviewed by 
Nolte and Osborne,44 the effect size reported for a con-
ceptually related self-efficacy measure were small to 
medium with median size effects of 0.30, with only one 
study reporting an effect size of 0.75. In relation to 
these results, we can conclude that the SMP pro-
gramme evaluated in this study was associated with 
medium effect size improvements in participants’ acti-
vation. The systematic review of trials assessing lay-led 
SMPs for people with chronic conditions (including 
pain) included 10 studies that assessed self-efficacy to 
manage pain.6 All these studies reported size effects 
smaller than in our study (ranging from −0.21 to 
−0.35); however, these were RCTs, while being more 
robust in design, with selected and more homogeneous 
patient groups, with less validity to a health service 
context.
In this study, while health state (EQ-VAS) did not 
change, health status (EQ 5D) improved. This out-
come was not included in the studies reviewed by 
Nolte and Osborne,44 but measures of physical func-
tion were assessed in four studies, and effects were very 
small or negligible. Foster et al.’s6 review included six 
Table 3. Distribution of the proportion of patients with ‘substantial improvement’, ‘minimal/no improvement’ or 
‘substantial decline’.
heiQ subscales Substantial improvement 
(ES ≥ 0.5)
Minimal/no change 
(–0.50 < ES < 0.50)
Substantial decline 
(ES ≤ –0.5)
Health Directed Behaviour (N = 79) 18.7% 62.6% 18.7%
Positive and Active Engagement (N = 78) 21.7% 61.3% 17%
Emotional Well-Being (N = 79) 26.2% 57.9% 15.9%
Self-Monitoring and Insight (N = 79) 21.5% 68.2% 10.3%
Constructive Attitude Shift (N = 78) 20.6% 65.4% 14%
Skills and Technique Acquisition (N = 77) 35.8% 56.6% 7.5%
Social Integration and Support (N = 78) 16.8% 61.7% 21.5%
Health Service Navigation (N = 78) 16.8% 65.4% 17.8%
heiQ: Health Education Impact Questionnaire.
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studies that assessed quality of life using EQ 5D. In 
these studies, size effects on this measure were signifi-
cantly smaller compared to those found in our study.
In this study, the improvement in depression scores 
was small; however, the effect size was larger compared 
to the median effect size from 10 trials (0.12).44 The 
scores for anxiety also improved (d = –0.27), but anxi-
ety was not included in the studies reviewed above.44
In our study, there were no improvements in Pain 
Severity, but we noticed significant improvement in 
Pain Interference (as measured by BPI). However, the 
effect sizes were very small which is consistent with the 
results from studies included in the reviews.6,44 
Surprisingly, in our study, Pain Self-Efficacy decreased 
6 months after completing the SMP programme. These 
findings are not consistent with results of three studies 
included in the review by Foster et al.6 that specifically 
assessed pain-related self-efficacy. All three studies 
noted small but significant improvements.
Improvements in self-management skills (as meas-
ured by heiQ) were greatest for Skills and Technique 
Acquisition and Self-Monitoring. Improvement on 
these two subscales were comparable to those reported 
on the same measure by the national self-manage-
ment evaluation in Australia.45 However, in regard to 
all remaining heiQ subscales, the proportion of 
patients in the Australian survey making a substantial 
improvement was greater.45 However, not all SMP 
programme attenders in the Australian study were 
pain patients, and intake of patients may differ in 
chronicity and severity of pain, so results are not 
directly comparable.
Adherence to the intervention may explain some of 
the variation in results achieved in different studies. 
For example, a study by Nicholas et al.16 of 567 par-
ticipants showed that patients who better adhere to 
self-management support strategies taught during a 
3-week cognitive-behavioural SMP for chronic muscu-
loskeletal pain showed more significant reductions in 
pain, disability and depressive symptoms compared to 
participants with poor adherence. In studies of CBT 
for pain, homework adherence has rarely been reported, 
and little is known about patient engagement beyond 
rates of session attendance and study drop-out. Research 
is needed on ways to enhance patients’ active participa-
tion in SMPs, as well as to develop measures that 
adequately capture such engagement.7
Commissioners of services must address issues of 
equity and access to services and aim to reduce health 
inequlities.46 The majority of participants were female 
and middle aged, in line with other studies reported in 
a systematic review of self-management group inter-
ventions. The patients were mainly White, and fewer of 
those from ethnic minorities completed the pro-
gramme, which may suggest that further development 
of culturally sensitive delivery may be beneficial. 
Education and house ownership variables show a wide 
range but also a median level, suggesting the pro-
gramme may have attracted more of those who are 
educated and have higher incomes. Further co-pro-
duction of recruitment methods and content with 
potential participants from a wide spectrum of a local-
ity is recommended.
Limitations of the study
First of all, the sample in the described study was self-
selected, thus the results need to be interpreted with 
caution. It is possible that patients who volunteered to 
participate in the SMP were highly motivated and 
interested in improving their quality of life. Comparison 
of completers and non-completers showed that patients 
who attended less than five SMP sessions scored sig-
nificantly lower on the Self-Monitoring and Insight 
subscale of heiQ at baseline. This may suggest that of 
patients who volunteered to attend the SMP, those 
who completed it were already more engaged in man-
aging their condition than those who dropped out early 
on. Second, the study design did not use a comparison 
group, so we cannot conclude with full certainty that 
observed improvements were solely the result of 
attending the SMP. Data were not achieved from all 
patients at each time point, leading to the possible 
response bias of those responding having better out-
comes than non-responders.
Implications and conclusion
The study provides an evaluation of the implementa-
tion of an evidence-based group SMP in the context of 
the English NHS. Over the 29-month recruitment 
period, 528 patients were recruited, 376 entered the 
programme and 308 completed at least five sessions. 
Comments by patients and clinicians (reported else-
where)47 suggest this high level of acceptance and 
retention was achieved in part by the conversations 
between clinicians and patients about the appropriate-
ness of the programme for their needs.40 We recom-
mend that future studies include data on healthcare 
use, which could be used by commissioners in a busi-
ness case for investment, since it is plausible that better 
self-management facilitate more appropriate health-
care use and may reduce costs of unnecessary investi-
gations and ineffective interventions. The study 
provides data on outcomes that are readily collected in 
routine practice. Services in the United Kingdom are 
mandated to use the primary outcome measure used 
here and commissioners will have valuable data on 
which to compare the improvements achieved from 
this type of programme in their local health services. 
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These results give support to the case for investment in 
supported SMPs for long-term pain, and for referral by 
clinicians such as GPs, musculo-skeletal and chronic 
pain management services.
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